Survival Response to Increased Ceramide Involves Metabolic Adaptation through Novel Regulators of Glycolysis and Lipolysis by Niraj K. Nirala (424266)

Caveolae Regulation of Mechanosensitive Channel Function in Myotubes by Haixia Huang (452278)

Image1.TIF by Anna Kovalchuk (4864324)

High-Throughput Sequencing Reveals Differential Expression of miRNAs in Intestine from Sea Cucumber during Aestivation by Muyan Chen (442619)

Medication use in children from the 2015 Pelotas (Brazil) birth cohort aged between three months and four years by Simone Farías-Antúnez (12740750)

“…We observed a decrease in the proportion of medically prescribed medications and an increase in self-medication over the years. …”

Table_2_Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness.doc by Juan Navarro-Barriuso (6856103)

Table_3_Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness.xls by Juan Navarro-Barriuso (6856103)

Image_5_A Population of M2 Macrophages Associated With Bone Formation.tif by Elizabeth Olmsted-Davis (11552029)

DataSheet1_Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review.docx by Peipei Xu (391804)

“…Five (62.5%) studies found a significant intervention effect during hospitalization, while 2 (25%) studies at ICU transfer and 2 (25%) studies at hospital discharge. 4 (50%) studies identified the complications related to SUP pharmacotherapy and found no significant difference. 4 (50%) studies declared the pharmacist-led interventions were associated with cost savings.…”

Table_4_Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness.xls by Juan Navarro-Barriuso (6856103)

Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity by Veronica R. Placencio (361478)

“…We demonstrated that these inhibitors decreased cell viability in several human cancer cell lines with an IC₅₀ in the 9.7 to 60.3 μM range and induced intrinsic apoptosis at concentrations of 50 μM. …”

Image2.TIF by Anna Kovalchuk (4864324)

Table_2_A Population of M2 Macrophages Associated With Bone Formation.docx by Elizabeth Olmsted-Davis (11552029)

Brittle Culm1, a COBRA-Like Protein, Functions in Cellulose Assembly through Binding Cellulose Microfibrils by Lifeng Liu (164546)

Table_1_A Population of M2 Macrophages Associated With Bone Formation.docx by Elizabeth Olmsted-Davis (11552029)

Pharmacologic suppression of GABA_A receptor function differentially affects sleep in control and GEFS+ flies. by Emily Petruccelli (794164)

The effect of bispectral index monitoring on cognitive performance following sedation for outpatient colonoscopy: a randomized controlled trial by Mehmet Sargin (5400356)

“…<div><p>ABSTRACT BACKGROUND: Bispectral index (BIS) monitoring can positively affect cognitive performance through decreasing the use of sedative agents. We aimed to evaluate the effect of BIS monitoring on early cognitive performance among patients undergoing sedation for colonoscopy. …”

The effect of bispectral index monitoring on cognitive performance following sedation for outpatient colonoscopy: a randomized controlled trial by Mehmet Sargin (5400356)

“…<div><p>ABSTRACT BACKGROUND: Bispectral index (BIS) monitoring can positively affect cognitive performance through decreasing the use of sedative agents. We aimed to evaluate the effect of BIS monitoring on early cognitive performance among patients undergoing sedation for colonoscopy. …”

Comparison of choroidal thickness in normal eyes and different ocular pathologies in a Brazilian population by Murilo U. Polizelli (10371024)

“…Results: Seventy-four eyes from 74 patients with a mean age of 51.4 years were analyzed in the normal group with a mean nasal, subfoveal and temporal choroidal thickness measurements were 301.30 ± 12.86 μm, 311.61 ± 12.62 μm and 309.28 ± 12.28 μm respectively. …”

Supplementary Material for: An early phase 2 double-blind, placebo-controlled study of E6011, a novel anti-fractalkine antibody, in patients with Crohn’s disease by figshare admin karger (2628495)

“…The primary efficacy endpoint was the percentage of patients who achieved a decrease in the CD activity index (CDAI) by ≥ 100 points from baseline at Week 12. …”